Pure ground-glass opacity neoplastic lung nodules: Histopathology, imaging, management

American Journal of Roentgenology

Volumn 202, Issue 3, 2014, Pages

  Lee, Ho Yun ^a   Choi, Yoon La ^a   Lee, Kyung Soo ^a   Han, Joungho ^a   Zo, Jae Ill ^a   Shim, Young Mog ^a   Moon, Jung Won ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adenocarcinoma in situ; CT; Ground glass opacity (ggo) nodule; High resolution ct (hrct); Lung adenocarcinoma; Minimally invasive adenocarcinoma; Solitary pulmonary nodule (spn)

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE; K RAS PROTEIN; PROTEIN P53;

CANCER PROGNOSIS; CANCER SCREENING; CANCER SURGERY; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; GROUND GLASS OPACITY LUNG NODULE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG FUNCTION; LUNG NODULE; PREVALENCE; PRIORITY JOURNAL; RADIATION ATTENUATION; REVIEW; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADENOCARCINOMA; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOGRAPHIC IMAGE ENHANCEMENT; SOLITARY PULMONARY NODULE;

EID: 84896697107     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.13.11819     Document Type: Review

References (58)

1. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6:244-285
2. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001; 220:803-809 (Pubitemid 32799993)
3. Kodama K, Higashiyama M, Yokouchi H, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001; 33:17-25 (Pubitemid 32586777)
4. Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002; 74:1635-1639 (Pubitemid 35222657)
5. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004; 28:198-206 (Pubitemid 38124728)
6. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. Br J Cancer 2005; 92:1033-1037 (Pubitemid 40546665)
7. Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging 2011; 26:106-118
8. Goo JM, Park CM, Lee HJ. Ground-glass nodules on chest CT as imaging biomarkers in the management of lung adenocarcinoma. AJR 2011; 196:533-543
9. Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol 2013; 31:992-1001
10. Fujita A, Kameda Y, Goya T. Clinicopathology of stromal invasion in lung adenocarcinoma. Pathol Int 2009; 59:1-6
11. Imai K, Minamiya Y, Goto A, et al. Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-beta1. World J Surg Oncol 2013; 11:113
12. Yoshida J, Nagai K, Yokose T, et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg 2005; 129:991-996 (Pubitemid 40631417)
13. Detterbeck FC, Homer RJ. Approach to the ground-glass nodule. Clin Chest Med 2011; 32:799-810
14. Thunnissen E, Beasley MB, Borczuk AC, et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma: an international interobserver study. Mod Pathol 2012; 25:1574-1583
15. Kazerooni EA. High-resolution CT of the lungs. AJR 2001; 177:501-519
16. Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993; 189:693-698 (Pubitemid 23354479)
17. Groshong SD, Lynch DA, Brown KK. Clinico-radiologic-pathologic collaboration: the challenge of interdisciplinary communication. J Thorac Imaging 2009; 24:250-251
18. Ikeda K, Awai K, Mori T, Kawanaka K, Yamashita Y, Nomori H. Differential diagnosis of ground-glass opacity nodules: CT number analysis by three-dimensional computerized quantification. Chest 2007; 132:984-990
19. Lim HJ, Ahn S, Lee KS, et al. Persistent pure ground-glass opacity lung nodules >/= 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013; 144:1291-1299
20. Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of sub-solid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013; 266:304-317
21. Lee SM, Park CM, Goo JM, Lee HJ, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013; 268:265-273
22. Shimosato Y, Suzuki A, Hashimoto T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 1980; 4:365-373 (Pubitemid 10035269)
23. Yamada N, Kusumoto M, Maeshima A, Suzuki K, Matsuno Y. Correlation of the solid part on high-resolution computed tomography with pathological scar in small lung adenocarcinomas. Jpn J Clin Oncol 2007; 37:913-917 (Pubitemid 351176481)
24. de Hoop B, Gietema H, van de Vorst S, Murphy K, van Klaveren RJ, Prokop M. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology 2010; 255:199-206
25. Lee HY, Jeong JY, Lee KS, et al. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers. Radiology 2012; 264:884-893
26. Yanagawa M, Tanaka Y, Kusumoto M, et al. Automated assessment of malignant degree of small peripheral adenocarcinomas using volumetric CT data: correlation with pathologic prognostic factors. Lung Cancer 2010; 70:286-294
27. Yoshizawa A, Sumiyoshi S, Sonobe M, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013; 8:52-61
28. Tsuta K, Kawago M, Inoue E, et al. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 2013; 81:371-376
29. Lee HJ, Kim YT, Kang CH, et al. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes. Radiology 2013; 268:254-264
30. Aoki T, Hanamiya M, Uramoto H, Hisaoka M, Yamashita Y, Korogi Y. Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers. Radiology 2012; 264:590-596
31. Chung JH, Choe G, Jheon S, et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. J Thorac Oncol 2009; 4:1490-1495
32. Borczuk AC, Qian F, Kazeros A, et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 2009; 33:462-469
33. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995; 75:2844-2852
34. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr 2004; 28:17-23 (Pubitemid 38057850)
35. Min JH, Lee HY, Lee KS, et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer 2010; 69:123-126
36. Seo JM, Lee HY, Kim HK, et al. Factors determining successful computed tomography-guided localization of lung nodules. J Thorac Cardiovasc Surg 2012; 143:809-814
37. El-Sherif A, Fernando HC, Santos R, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 2007; 14:2400-2405 (Pubitemid 47174921)
38. Ohtsuka T, Watanabe K, Kaji M, Naruke T, Suemasu K. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg 2006; 30:160-163 (Pubitemid 43850329)
39. Watanabe S, Watanabe T, Arai K, Kasai T, Haratake J, Urayama H. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg 2002; 73:1071-1075 (Pubitemid 34275880)
40. Rami-Porta R, Tsuboi M. Sublobar resection for lung cancer. Eur Respir J 2009; 33:426-435
41. Blasberg JD, Pass HI, Donington JS. Sublobar resection: a movement from the Lung Cancer Study Group. J Thorac Oncol 2010; 5:1583-1593
42. Shrager JB. Approach to the patient with multiple lung nodules. Thorac Surg Clin 2013; 23:257-266
43. Rami-Porta R, Wittekind C, Goldstraw P; Complete Resection Subcommittee of the IASLC Staging Committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005; 49:25-33 (Pubitemid 40798090)
44. Ishiguro F, Matsuo K, Fukui T, Mori S, Hatooka S, Mitsudomi T. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score. J Thorac Cardiovasc Surg 2010; 139:1001-1006
45. Asamura H, Hishida T, Suzuki K, et al. Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201. J Thorac Cardiovasc Surg 2013; 146:24-30
46. Nakao M, Yoshida J, Goto K, et al. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. J Thorac Oncol 2012; 7:1563-1566
47. Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007; 242:555-562 (Pubitemid 46146208)
48. Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008; 3:781-792
49. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000; 73:1252-1259 (Pubitemid 32123826)
50. Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006; 81:413-419 (Pubitemid 43120527)
51. Chang B, Hwang JH, Choi YH, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013; 143:172-178
52. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012; 144:33-38
53. National Comprehensive Cancer Network (NCNN) website. NCCN guidelines for detection, prevention, and risk reduction: lung cancer screening. www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed August 8, 2013
54. Oda S, Awai K, Murao K, et al. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: assessment with computer-aided three-dimensional volumetry. Acad Radiol 2011; 18:63-69
55. Park JH, Lee KS, Kim JH, et al. Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Korean J Radiol 2009; 10:12-20
56. Kim HK, Choi YS, Kim J, Shim YM, Lee KS, Kim K. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010; 5:206-210
57. Gandara DR, West H, Chansky K, et al. Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition. Clin Cancer Res 2004; 10(12 Pt 2):4205s-4209s (Pubitemid 38812447)
58. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002; 73:386-392; discussion, 392-393